HBB_HUMAN - dbPTM
HBB_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HBB_HUMAN
UniProt AC P68871
Protein Name Hemoglobin subunit beta
Gene Name HBB
Organism Homo sapiens (Human).
Sequence Length 147
Subcellular Localization
Protein Description Involved in oxygen transport from the lung to the various peripheral tissues.; LVV-hemorphin-7 potentiates the activity of bradykinin, causing a decrease in blood pressure.; Spinorphin: functions as an endogenous inhibitor of enkephalin-degrading enzymes such as DPP3, and as a selective antagonist of the P2RX3 receptor which is involved in pain signaling, these properties implicate it as a regulator of pain and inflammation..
Protein Sequence MVHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2N-pyruvate 2-iminyl-valine------MVHLTPEEK
------CCCCCHHHH
5.21-
2Acetylation------MVHLTPEEK
------CCCCCHHHH
5.21-
2Other------MVHLTPEEK
------CCCCCHHHH
5.21-
2N-linked_Glycosylation------MVHLTPEEK
------CCCCCHHHH
5.21635569
5Phosphorylation---MVHLTPEEKSAV
---CCCCCHHHHHHH
17.4923025827
9N-linked_GlycosylationVHLTPEEKSAVTALW
CCCCHHHHHHHHHHH
41.897358733
9GlycationVHLTPEEKSAVTALW
CCCCHHHHHHHHHHH
41.89-
9AcetylationVHLTPEEKSAVTALW
CCCCHHHHHHHHHHH
41.897666987
10PhosphorylationHLTPEEKSAVTALWG
CCCHHHHHHHHHHHC
31.1125072903
13PhosphorylationPEEKSAVTALWGKVN
HHHHHHHHHHHCCCC
18.7524702127
18AcetylationAVTALWGKVNVDEVG
HHHHHHCCCCHHHCC
21.0320167786
18N-linked_GlycosylationAVTALWGKVNVDEVG
HHHHHHCCCCHHHCC
21.037358733
18GlycationAVTALWGKVNVDEVG
HHHHHHCCCCHHHCC
21.03-
36PhosphorylationLGRLLVVYPWTQRFF
HHHHEEHHHHHHHHH
5.8821082442
36NitrationLGRLLVVYPWTQRFF
HHHHEEHHHHHHHHH
5.88-
39PhosphorylationLLVVYPWTQRFFESF
HEEHHHHHHHHHHHH
12.8328857561
45O-linked_GlycosylationWTQRFFESFGDLSTP
HHHHHHHHHCCCCCC
29.40OGP
45PhosphorylationWTQRFFESFGDLSTP
HHHHHHHHHCCCCCC
29.4024972180
50O-linked_GlycosylationFESFGDLSTPDAVMG
HHHHCCCCCCCHHCC
42.5120166139
50PhosphorylationFESFGDLSTPDAVMG
HHHHCCCCCCCHHCC
42.5123025827
51PhosphorylationESFGDLSTPDAVMGN
HHHCCCCCCCHHCCC
32.2723025827
56SulfoxidationLSTPDAVMGNPKVKA
CCCCCHHCCCHHHCC
4.6221192028
60AcetylationDAVMGNPKVKAHGKK
CHHCCCHHHCCCCCE
61.444531009
62AcetylationVMGNPKVKAHGKKVL
HCCCHHHCCCCCEEE
40.577675277
66AcetylationPKVKAHGKKVLGAFS
HHHCCCCCEEEHHHH
29.8230583883
67N-linked_GlycosylationKVKAHGKKVLGAFSD
HHCCCCCEEEHHHHH
47.487358733
67GlycationKVKAHGKKVLGAFSD
HHCCCCCEEEHHHHH
47.48-
73PhosphorylationKKVLGAFSDGLAHLD
CEEEHHHHHHHHHHH
30.1823025827
73O-linked_GlycosylationKKVLGAFSDGLAHLD
CEEEHHHHHHHHHHH
30.1820166139
83AcetylationLAHLDNLKGTFATLS
HHHHHHCCCHHHHHH
63.264531009
85PhosphorylationHLDNLKGTFATLSEL
HHHHCCCHHHHHHHH
14.4423312004
85O-linked_GlycosylationHLDNLKGTFATLSEL
HHHHCCCHHHHHHHH
14.4412556445
88PhosphorylationNLKGTFATLSELHCD
HCCCHHHHHHHHCCC
26.9926657352
90PhosphorylationKGTFATLSELHCDKL
CCHHHHHHHHCCCCC
33.4823025827
94S-nitrosylationATLSELHCDKLHVDP
HHHHHHCCCCCCCCH
8.469843411
94GlutathionylationATLSELHCDKLHVDP
HHHHHHCCCCCCCCH
8.4616051210
94S-nitrosocysteineATLSELHCDKLHVDP
HHHHHHCCCCCCCCH
8.46-
94MethylationATLSELHCDKLHVDP
HHHHHHCCCCCCCCH
8.46-
96AcetylationLSELHCDKLHVDPEN
HHHHCCCCCCCCHHH
45.9825038526
113S-nitrosylationLLGNVLVCVLAHHFG
HHHHHHHHHHHHHHC
1.4925040305
121GlycationVLAHHFGKEFTPPVQ
HHHHHHCCCCCHHHH
49.03-
121N-linked_GlycosylationVLAHHFGKEFTPPVQ
HHHHHHCCCCCHHHH
49.037358733
121AcetylationVLAHHFGKEFTPPVQ
HHHHHHCCCCCHHHH
49.037669925
124PhosphorylationHHFGKEFTPPVQAAY
HHHCCCCCHHHHHHH
27.9823911959
131NitrationTPPVQAAYQKVVAGV
CHHHHHHHHHHHHHH
16.34-
131PhosphorylationTPPVQAAYQKVVAGV
CHHHHHHHHHHHHHH
16.3421253578
133AcetylationPVQAAYQKVVAGVAN
HHHHHHHHHHHHHHH
26.467684877
145N-linked_GlycosylationVANALAHKYH-----
HHHHHHHCCC-----
39.147358733
145GlycationVANALAHKYH-----
HHHHHHHCCC-----
39.14-
145AcetylationVANALAHKYH-----
HHHHHHHCCC-----
39.144531009
146NitrationANALAHKYH------
HHHHHHCCC------
11.68-
146PhosphorylationANALAHKYH------
HHHHHHCCC------
11.6828857561

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of HBB_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
60KAcetylation

4531009
83KAcetylation

4531009
145KAcetylation

4531009

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference
2N-linked Glycosylation7 (5)EV;Krs334;rs33930165
  • Urinary albumin-to-creatinine ratio
  • Hematocrit
  • Mean corpuscular hemoglobin concentration
  • Mean corpuscular volume
  • Severe malaria
27650483
28453575
29381699
5Phosphorylation7 (2)EV;Krs334;rs33930165
  • Urinary albumin-to-creatinine ratio
  • Hematocrit
  • Mean corpuscular hemoglobin concentration
  • Mean corpuscular volume
  • Severe malaria
27650483
28453575
29381699
9Acetylation7 (2)EV;Krs334;rs33930165
  • Urinary albumin-to-creatinine ratio
  • Hematocrit
  • Mean corpuscular hemoglobin concentration
  • Mean corpuscular volume
  • Severe malaria
27650483
28453575
29381699
10Phosphorylation7 (3)EV;Krs334;rs33930165
  • Urinary albumin-to-creatinine ratio
  • Hematocrit
  • Mean corpuscular hemoglobin concentration
  • Mean corpuscular volume
  • Severe malaria
27650483
28453575
29381699
13Phosphorylation7 (6)EV;Krs334;rs33930165
  • Urinary albumin-to-creatinine ratio
  • Hematocrit
  • Mean corpuscular hemoglobin concentration
  • Mean corpuscular volume
  • Severe malaria
27650483
28453575
29381699

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SELT_HUMANSELTphysical
16169070
HBA_HUMANHBA1physical
6644819

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
140700Heinz body anemias (HEIBAN)
613985Beta-thalassemia (B-THAL)
603903Sickle cell anemia (SKCA)
603902Beta-thalassemia, dominant, inclusion body type (B-THALIB)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00893Iron Dextran
Regulatory Network of HBB_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Sites of nonenzymatic glycosylation of human hemoglobin A.";
Shapiro R., McManus M.J., Zalut C., Bunn H.F.;
J. Biol. Chem. 255:3120-3127(1980).
Cited for: GLYCATION AT LYS-9; LYS-18; LYS-67; LYS-121 AND LYS-145, AND LACK OFGLYCATION AT LYS-60; LYS-83 AND LYS-96.
"The glycosylation of hemoglobin: relevance to diabetes mellitus.";
Bunn H.F., Gabbay K.H., Gallop P.M.;
Science 200:21-27(1978).
Cited for: GLYCATION AT VAL-2.
Phosphorylation
ReferencePubMed
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-131, AND MASSSPECTROMETRY.
S-nitrosylation
ReferencePubMed
"Crystal structure of the S-nitroso form of liganded humanhemoglobin.";
Chan N.L., Rogers P.H., Arnone A.;
Biochemistry 37:16459-16464(1998).
Cited for: S-NITROSYLATION AT CYS-94.
"S-nitrosohaemoglobin: a dynamic activity of blood involved invascular control.";
Jia L., Bonaventura C., Bonaventura J., Stamler J.S.;
Nature 380:221-226(1996).
Cited for: S-NITROSYLATION AT CYS-94.

TOP